The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Abu Dhabi identifies over 40 modern heritage sites
Distribution of aid from UAE's Saqr Humanitarian Ship begins in Gaza
Dubai to expand bus and taxi lanes as public transport ridership grows by 7.4%
Emir of Qatar welcomed by UAE President on visit to Abu Dhabi
UAE, Egypt Foreign Ministers discuss Gaza peace plan
